George Wang

George Wang is a Senior Director of Corporate Development at Gilead Sciences, where responsibilities include overseeing Transaction Finance with a focus on mergers and acquisitions, licensing, collaborations, divestitures, and equity investments since July 2021. Prior to Gilead, George Wang held several roles in corporate development at PJT Partners from 2018 to 2021, culminating in the position of Vice President of Strategic Advisory specializing in healthcare M&A. Previous experience includes serving as an Associate in Investment Banking at Guggenheim Partners and as a Senior Analyst at Compass Lexecon, where expertise encompassed M&A litigation, statistical modeling, and econometrics. Academic qualifications include a Bachelor of Arts in Economics from Princeton University, an MBA in Accounting and Finance from Columbia Business School, and additional studies at Harvard University.